Trading volume in foreign shares on SPB Exchange falls 36% MoM in Sept, down 78% YoY to $5.9 bln
MOSCOW. Oct 5 (Interfax) - Trading volume in foreign securities in the main trading mode of the SPB Exchange fell 36.1% month-on-month in September to $5.85 billion from $9.16 in August and was down 78.2% compared to September 2021 ($26.79 billion), the exchange said in a statement.
Average daily trading volume in the "foreign securities" group in September decreased by 30.1% compared to August and amounted to $0.28 billion.
7.90 million deals were made by participants of trades in basic trading in September compared to 12.46 million deals in August (36.6% decrease).
Participants of trading in main trading mode concluded 7.90 million transactions in September compared with 12.46 million transactions in August (down 36.6%).
The number of active investor accounts decreased by 3.4% in September and amounted to 352,820 (365,400 in August). The number of accounts with positions on securities totaled 1.76 million.
Transactions in September were concluded with 1,721 shares and depositary receipts of international companies.
The leaders in terms of volume of trading in the main foreign securities trading mode in September were shares and depositary receipts of Tesla (11.1% of the total volume of trading in the main foreign securities trading mode in September), Coinbase Global (8.3%), NVIDIA Corp. (6.6%), Alibaba (3.2%), Apple Inc. (2.8%), Netflix Inc. (2.0%), Carnival Corp. (1.8%), MicroStrategy Inc. (1.7%), Advanced Micro Devices (1.7%) and Snap Inc. .
The value of transactions in main trading mode of Hong Kong securities decreased by 15.9% in September compared to August and amounted to HK$0.39 billion.
Trading participants and their clients in the main trade mode in September carried out 72,460 transactions with Hong Kong securities (down 19.9% compared to August). The number of active investor accounts in the main trade mode amounted to 15,250 (down 20.8% as compared with August).
The leaders in trading were shares of Alibaba, Xiaomi Corp, JD.com Inc, Tencent Holdings Ltd, Sino Biopharmaceutical Ltd.